Advanced search
Publication Cover
Future Medicinal Chemistry Volume 2, 2010 - Issue 1
Submit an article Journal homepage
487
Views
0
CrossRef citations to date
0
Altmetric
Review

Mechanisms of Brain Iron Transport: Insight into Neurodegeneration and CNS Disorders

Eric Mills1 Department of Molecular, Cellular, and Developmental Biology, University of Michigan, 3089 Natural Science Building (Kraus), 830 North University, Ann Arbor, MI48109, USAView further author information
,
Xian-ping Dong1 Department of Molecular, Cellular, and Developmental Biology, University of Michigan, 3089 Natural Science Building (Kraus), 830 North University, Ann Arbor, MI48109, USAView further author information
,
Fudi Wang2 Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai200031, PR ChinaView further author information
&
Haoxing Xu1 Department of Molecular, Cellular, and Developmental Biology, University of Michigan, 3089 Natural Science Building (Kraus), 830 North University, Ann Arbor, MI48109, USACorrespondence[email protected]
View further author information
Pages 51-64 | Published online: 22 Dec 2009

Bibliography

  • Fillebeen C , DescampsL, DehouckMPet al. Receptor-mediated transcytosis of lactoferrin through the blood–brain barrier. J. Biol. Chem. 274(11), 7011–7017 (1999).
  • Richardson DR , PonkaP. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.Biochim. Biophys. Acta.1331(1), 1–40 (1997).
  • Rothenberger S , FoodMR, GabathulerRet al. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium. Brain Res. 712(1), 117–121 (1996).
  • Hentze MW , MuckenthalerMU, AndrewsNC. Balancing acts: molecular control of mammalian iron metabolism.Cell117(3), 285–297 (2004).
  • Moos T , RosengrenNT, Skj⊘rringeT, MorganEH. Iron trafficking inside the brain.J. Neurochem.103(5), 1730–1740 (2007).
  • Todorich B , PasquiniJM, GarciaCI, PaezPM, ConnorJR. Oligodendrocytes and myelination: the role of iron.Glia57(5), 467–478 (2009).
  • Ke Y , QianZM. Brain iron metabolism: neurobiology and neurochemistry.Prog. Neurobiol.83(3), 149–173 (2007).
  • Zecca L , YoudimMB, RiedererP, ConnorJR, CrichtonRR. Iron, brain ageing and neurodegenerative disorders.Nat. Rev. Neurosci.5(11), 863–873 (2004).
  • Lozoff B , GeorgieffMK. Iron deficiency and brain development.Semin. Pediatr. Neurol.13(3), 158–165 (2006).
  • Pollitt E . Early iron deficiency anemia and later mental retardation.Am. J. Clin. Nutr.69(1), 4–5 (1999).
  • Schipper HM . Brain iron deposition and the free radical–mitochondrial theory of ageing.Ageing Res. Rev.3(3), 265–301 (2004).
  • Lillig CH , BerndtC, HolmgrenA. Glutaredoxin systems.Biochim. Biophys. Acta.1780(11), 1304–1317 (2008).
  • MacKenzie EL , IwasakiK, TsujiY. Intracellular iron transport and storage: from molecular mechanisms to health implications.Antioxid. Redox Signal10(6), 997–1030 (2008).
  • Berg D , HochstrasserH. Iron metabolism in Parkinsonian syndromes.Mov. Disord.21(9), 1299–1310 (2006).
  • Lee DW , AndersenJK, KaurD. Iron dysregulation and neurodegeneration: the molecular connection.Mol. Interv.6(2), 89–97 (2006).
  • Abo-Krysha N , RashedL. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.Mult. Scler.14(5), 602–608 (2008).
  • Barnham KJ , BushAI. Metals in Alzheimer’s and Parkinson’s diseases.Curr. Opin. Chem. Biol.12(2), 222–228 (2008).
  • Moos T , MorganEH. The metabolism of neuronal iron and its pathogenic role in neurological disease: review.Ann. NY Acad. Sci.1012, 14–26 (2004).
  • Zhou B , WestawaySK, LevinsonB, JohnsonMA, GitschierJ, HayflickSJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden–Spatz syndrome.Nat. Genet.28(4), 345–349 (2001).
  • Morgan NV , WestawaySK, MortonJEet al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat. Genet. 38(7), 752–754 (2006).
  • Harris ZL , DurleyAP, ManTK, GitlinJD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux.Proc. Natl Acad. Sci. USA96(19), 10812–10817 (1999).
  • Curtis AR , FeyC, MorrisCMet al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet.28(4), 350–354 (2001).
  • Clardy SL , WangX, BoyerPJ, EarleyCJ, AllenRP, ConnorJR. Is ferroportin–hepcidin signaling altered in restless legs syndrome?J. Neurol. Sci.247(2), 173–179 (2006).
  • Hua Y , KeepRF, HoffJT, XiG. Brain injury after intracerebral hemorrhage: the role of thrombin and iron.Stroke38(Suppl. 2), 759–762 (2007).
  • Sun M , GoldinE, StahlSet al. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum. Mol. Genet. 9(17), 2471–2478 (2000).
  • Dong XP , ChengX, MillsEet al. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455(7215), 992–996 (2008).
  • LaVaute T , SmithS, CoopermanSet al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27(2), 209–214 (2001).
  • Rouault TA . The role of iron regulatory proteins in mammalian iron homeostasis and disease.Nat. Chem. Biol.2(8), 406–414 (2006).
  • Crapper McLachlan DR , DaltonAJ, KruckTPet al. Intramuscular desferrioxamine in patients with Alzheimer’s disease. Lancet 337(8753), 1304–1308 (1991).
  • Benvenisti-Zarom L , ChenJ, ReganRF. The oxidative neurotoxicity of clioquinol.Neuropharmacology49(5), 687–694 (2005).
  • Kaur D , YantiriF, RajagopalanSet al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson’s disease. Neuron 37(6), 899–909 (2003).
  • Salazar J , MenaN, HunotSet al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson’s disease. Proc. Natl Acad. Sci. USA 105(47), 18578–18583 (2008).
  • Sayre LM , PerryG, SmithMA. Redox metals and neurodegenerative disease.Curr. Opin. Chem. Biol.3(2), 220–225 (1999).
  • Smith DG , CappaiR, BarnhamKJ. The redox chemistry of the Alzheimer’s disease amyloid b peptide.Biochim. Biophys. Acta.1768(8), 1976–1990 (2007).
  • Patel BN , DavidS. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes.J. Biol. Chem.272(32), 20185–20190 (1997).
  • Tsushima RG , WickendenAD, BouchardRAet al. Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ. Res. 84(11), 1302–1309 (1999).
  • Bradbury MW . Transport of iron in the blood–brain-cerebrospinal fluid system.J. Neurochem.69(2), 443–454 (1997).
  • Savman K , NilssonbUA, ThoresencM, KjellmeraI. Non-protein-bound iron in brain interstitium of newborn pigs after hypoxia.Dev. Neurosci.27(2–4), 176–184 (2005).
  • Petrat FH , de GrootRauen U. Determination of the chelatable iron pool of single intact cells by laser scanning microscopy. Arch. Biochem. Biophys.376(1), 74–81 (2000).
  • Andrews NC . Forging a field: the golden age of iron biology.Blood112(2), 219–230 (2008).
  • De Domenico I , McVey WardD, KaplanJ. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat. Rev. Mol. Cell Biol.9(1), 72–81 (2008).
  • Andrews NC , SchmidtPJ. Iron homeostasis.Annu. Rev. Physiol. 2007. 69, 69–85.
  • Garrick MD , GarrickLM. Cellular iron transport.Biochim. Biophys. Acta.1790(5), 309–325 (2009).
  • McKie AT , BarrowD, Latunde-DadaGOet al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291(5509), 1755–1759 (2001).
  • Gunshin H , MackenzieB, BergerUVet al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388(6641), 482–488 (1997).
  • Donovan A , BrownlieA, ZhouYet al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403(6771), 776–781 (2000).
  • Vulpe CD , KuoYM, MurphyTLet al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the SLA mouse. Nat. Genet. 21(2), 195–199 (1999).
  • Ohgami RS , CampagnaDR, GreerELet al. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat. Genet. 37(11), 1264–1269(2005).
  • Shaw GC , CopeJJ, LiLet al. Mitoferrin is essential for erythroid iron assimilation. Nature 440(7080), 96–100 (2006).
  • Kidane TZ , SaubleE, LinderMC. Release of iron from ferritin requires lysosomal activity.Am. J. Physiol. Cell Physiol.291(3), C445–C455 (2006).
  • Gunshin H , FujiwaraY, CustodioAO, DirenzoC, RobineS, AndrewsNC. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver.J. Clin. Invest.115(5), 1258–1266 (2005).
  • Ohgami RS , CampagnaDR, McDonaldA, FlemingMD. The Steap proteins are metalloreductases.Blood108(4), 1388–1394 (2006).
  • Lam-Yuk-Tseung S , GrosP. Distinct targeting and recycling properties of two isoforms of the iron transporter DMT1 (NRAMP2, Slc11A2).Biochemistry45(7), 2294–2301 (2006).
  • Jabado N , JankowskiA, DougaparsadS, PicardV, GrinsteinS, GrosP. Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane.J. Exp. Med.192(9), 1237–1248 (2000).
  • Puertollano R , KiselyovK. TRPMLs: in sickness and in health.Am. J. Physiol. Renal Physiol.296(6), F1245–F1254 (2009).
  • Nguyen A , ZhaoN, MorrisonCet al. Mechanisms of iron release from lysosomes. FASEB. 921, 11 (2009).
  • Wang F , ParadkarPN, CustodioAOet al. Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice. Nat. Genet. 39(8), 1025–1032 (2007).
  • Zerial M , McBrideH. Rab proteins as membrane organizers.Nat. Rev. Mol. Cell Biol.2(2), 107–117 (2001).
  • Pal A , SeverinF, LommerB, ShevchenkoA, ZerialM. Huntingtin–HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington’s disease.J. Cell Biol.172(4), 605–618 (2006).
  • Lumsden AL , HenshallTL, DayanS, LardelliMT, RichardsRI. Huntingtin-deficient zebrafish exhibit defects in iron utilization and development.Hum. Mol. Genet.16(16), 1905–1920 (2007).
  • Burdo JR , MenziesSL, SimpsonIAet al. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66(6), 1198–1207 (2001).
  • Jefferies WA , BrandonMR, HuntSV, WilliamsAF, GatterKC, MasonDY. Transferrin receptor on endothelium of brain capillaries.Nature312(5990), 162–163 (1984).
  • Abbott NJ , RonnbackL, HanssonE. Astrocyte–endothelial interactions at the blood–brain barrier.Nat. Rev. Neurosci.7(1), 41–53 (2006).
  • Moos T , MorganEH. Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid.J. Neurosci. Res.54(4), 486–494 (1998).
  • Burdo JR , AntonettiDA, WolpertEB, ConnorJR. Mechanisms and regulation of transferrin and iron transport in a model blood–brain barrier system.Neuroscience121(4), 883–890 (2003).
  • Burdo JR , ConnorJR. Brain iron uptake and homeostatic mechanisms: an overview.Biometals16(1), 63–75 (2003).
  • Beard JL , WiesingerJA, LiN, ConnorJR. Brain iron uptake in hypotransferrinemic mice: influence of systemic iron status.J. Neurosci. Res.79(1–2), 254–261 (2005).
  • Fisher J , DevrajK, IngramJet al. Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am. J. Physiol. Cell Physiol. 293(2), C641–C649 (2007).
  • Li JY , ParagasN, NedRMet al. Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev. Cell 16(1), 35–46 (2009).
  • Todorich B , ZhangX, Slagle-WebbB, SeamanWE, ConnorJR. Tim-2 is the receptor for H-ferritin on oligodendrocytes.J. Neurochem.107(6), 1495–1505 (2008).
  • Siddappa AJ , RaoRB, WobkenJD, LeiboldEA, ConnorJR, GeorgieffMK. Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain.J. Neurosci. Res.68(6), 761–775 (2002).
  • Mackenzie B , UjwalML, ChangMH, RomeroMF, HedigerMA. Divalent metal-ion transporter DMT1 mediates both H+-coupled Fe2+ transport and uncoupled fluxes. Pflugers Arch.451(4), 544–558 (2006).
  • Wu LJ , LeendersAG, CoopermanSet al. Expression of the iron transporter ferroportin in synaptic vesicles and the blood–brain barrier. Brain Res. 1001(1–2), 108–117 (2004).
  • Moos T , SkjoerringeT, GoskS, MorganEH. Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1.J. Neurochem.98(6), 1946–1958 (2006).
  • Donovan A , LimaCA, PinkusJLet al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1(3), 191–200 (2005).
  • Montana V , MalarkeyEB, VerderioC, MatteoliM, ParpuraV. Vesicular transmitter release from astrocytes.Glia54(7), 700–715 (2006).
  • Reddy A , CalerEV, AndrewsNW. Plasma membrane repair is mediated by Ca2+-regulated exocytosis of lysosomes. Cell106(2), 157–169 (2001).
  • Dringen R , BishopGM, KoeppeM, DangTN, RobinsonSR. The pivotal role of astrocytes in the metabolism of iron in the brain.Neurochem. Res.32(11), 1884–1890 (2007).
  • Qian ZM , ToY, TangPL, FengYM. Transferrin receptors on the plasma membrane of cultured rat astrocytes.Exp. Brain Res.129(3), 473–476 (1999).
  • Xu J , LingEA. Studies of the ultrastructure and permeability of the blood–brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers.J. Anat.184(2), 227–237 (1994).
  • Ham D , SchipperHM. Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides.Cell Mol. Biol.46(3), 587–596 (2000).
  • Jeong SY , DavidS. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system.J. Biol. Chem.278(29), 27144–27148 (2003).
  • Kaneko K , YoshidaK, ArimaKet al. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia. J. Neuropathol. Exp. Neurol. 61(12), 1069–1077 (2002).
  • Vargas JD , HerpersB, McKieAT. Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases.Biochim. Biophys. Acta.1651(1–2), 116–123 (2003).
  • Liuzzi JP , AydemirF, NamH, KnutsonMD, CousinsRJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells.Proc. Natl Acad. Sci. USA103(37), 13612–13617 (2006).
  • Oudit GY , SunH, TrivieriMGet al. l-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat. Med. 9(9), 1187–1194 (2003).
  • Mwanjewe J , GroverAK. Role of transient receptor potential canonical 6 (TRPC6) in non-transferrin-bound iron uptake in neuronal phenotype PC12 cells.Biochem. J.378(3), 975–982 (2004).
  • Kurz T , TermanA, GustafssonB, BrunkUT. Lysosomes in iron metabolism, ageing and apoptosis.Histochem.Cell Biol.129(4), 389–406 (2008).
  • Carlson ES , TkacI, MagidRet al. Iron is essential for neuron development and memory function in mouse hippocampus. J. Nutr. 139(4), 672–679 (2009).
  • Hulet SW , HessEJ, DebinskiWet al. Characterization and distribution of ferritin binding sites in the adult mouse brain. J. Neurochem. 72(2), 868–874 (1999).
  • Taylor EM , CroweA, MorganEH. Transferrin and iron uptake by the brain: effects of altered iron status.J. Neurochem.57(5), 1584–1592 (1991).
  • Chang J , JallouliY, KroubiMet al. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood–brain barrier. Int. J. Pharm. 379(2), 285–292 (2009).
  • Liu G , MenP, KudoW, PerryG, SmithMA. Nanoparticle-chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.Neurosci. Lett.455(3), 187–190 (2009).
  • Persson HL , YuZ, TiroshO, EatonJW, BrunkUT. Prevention of oxidant-induced cell death by lysosomotropic iron chelators.Free Radic. Biol. Med.34(10), 1295–1305 (2003).
  • Boado RJ , ZhangY, WangY, PardridgeWM. Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood–brain barrier delivery in the mouse.Biotechnol. Bioeng.102(4), 1251–1258 (2009).
  • Boado RJ , ZhangY, WangY, PardridgeWM. Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia.Hum. Mol. Genet.14(1), 49–57 (2005).
  • Balsinde J , BalboaMA. Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells.Cell Signal.17(9), 1052–1062 (2005).
  • De S , TriguerosMA, KalyvasA, DavidS. Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration.Mol. Cell Neurosci.24(3), 753–765 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.